Rays Of Belief IPO: GMP, Pricing, Allotment Details Unveiled with 2026 Profit Estimates

Rays of Belief, a for-profit social enterprise focused on providing personalized intervention plans for children with Neurodevelopmental Disorders (NDDs), is set to launch its IPO from September 1 to September 3, 2026. The company aims to issue 5,230,000 shares, consisting solely of a fresh issue with no offer for sale. The minimum bid lot size and issue price details are pending, but the company is listed on both the NSE and BSE, which indicates enhanced visibility and accessibility for investors. As an established player with a network of 136 centers in India and some in the United States, its expansion strategy demonstrates solid growth potential in an underserved market.

Grey market sentiment surrounding the Rays of Belief IPO has ignited interest among investors, as evidenced by preliminary discussions that suggest a positive outlook for the listing. The company’s unique focus on NDDs and its proven track record of serving over 58,000 children positions it well within a niche market that is growing in awareness and demand. While specific grey market premiums have yet to be confirmed, the company’s financial performance—showing increasing revenues and net income—suggests potential investor confidence leading up to the opening date.

For Indian investors, the Rays of Belief IPO offers an opportunity to invest in a company that not only promises financial returns but also contributes to social welfare by addressing significant gaps in developmental care for children. The funds raised will be directed towards capital expenditures for new centers, lease payments, brand awareness, and growth through acquisitions, all of which reinforce the company’s long-term vision. As societal awareness of neurodevelopmental disorders continues to rise, investing in Rays of Belief could yield sustainable growth while supporting a socially responsible mission.


Source: The Economic Times

(Expert Note: This report was prepared by the Wealthova IPO team.)